![]() |
|
|
Vol. 285, Issue 3, 1031-1038, June 1998
Departments of
Anesthesiology (T.L.Y.) and
Pharmacology (D.M.D.,
T.L.Y.), University of California, San Diego, California
Intrathecal administration of nonsteroidal anti-inflammatory drugs in
the rat blocks the thermal hyperalgesia induced by tissue injury, which
suggests a role for spinal cyclooxygenase (COX) products in this
facilitated state. Two isozymes of the COX enzyme have been reported,
COX-1 and COX-2, but the agents thus far examined are not isozyme
selective. We examined the effects of intrathecally (i.t.) or
systemically (i.p.) administered S(+)-ibuprofen (a
nonselective COX inhibitor) or
1-[(4-methysulfonyl)phenyl]-3-tri-fluoromethyl-5-(4-fluorophenyl) pyrazole (SC58125; a COX-2 selective inhibitor) on carrageenan-induced thermal hyperalgesia (reduced hindpaw-withdrawal latency). The following observations were made: 1) Thermal hyperalgesia otherwise observed during the first 170 min was blocked in a dose-dependent manner by S(+)-ibuprofen or SC58125 administered i.t. or
i.p. before carrageenan treatment. 2) Intraperitoneal, but not i.t., administration of either inhibitor after the establishment of hyperalgesia (170 min after carrageenan injection) reversed thermal hyperalgesia in a dose-dependent manner. Thus, the initial component of
thermal hyperalgesia after tissue injury was blocked by systemic or
spinal administration of both COX inhibitors, whereas established hyperalgesia was reversed only by systemic inhibitors. This study demonstrates that at least spinal COX-2, if not both COX-1 and COX-2,
are necessary for the initiation of thermal hyperalgesia, whereas
nonspinal sources of prostanoids (synthesized by COX-2 and perhaps also
COX-1) are important for the maintenance of thermal hyperalgesia
associated with tissue injury and inflammation.
This article has been cited by other articles:
![]() |
C.-M. Shih, S.-N. Cheng, C.-S. Wong, Y.-L. Kuo, and T.-C. Chou Antiinflammatory and Antihyperalgesic Activity of C-Phycocyanin Anesth. Analg., April 1, 2009; 108(4): 1303 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Brooks, N. Nametz, R. Charles, and T. P. Davis Diclofenac Attenuates the Regional Effect of {lambda}-Carrageenan on Blood-Brain Barrier Function and Cytoarchitecture J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Chillingworth, S. G. Morham, and L. F. Donaldson Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R327 - R334. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. H. Huntjens, M. Danhof, and O. E. Della Pasqua Pharmacokinetic pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors Rheumatology, July 1, 2005; 44(7): 846 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Priest, B. A. Murphy, J. A. Lindia, C. Diaz, C. Abbadie, A. M. Ritter, P. Liberator, L. M. Iyer, S. F. Kash, M. G. Kohler, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior PNAS, June 28, 2005; 102(26): 9382 - 9387. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, D. R. Conklin, and J. C. Eisenach Preoperative Inhibition of Cyclooxygenase-1 in the Spinal Cord Reduces Postoperative Pain Anesth. Analg., May 1, 2005; 100(5): 1390 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, P. Lebrun, F. Camu, and M. Zizi Intrathecal Catheterization and Solvents Interfere with Cortical Somatosensory Evoked Potentials Used in Assessing Nociception in Awake Rats Anesth. Analg., July 1, 2004; 99(1): 159 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guay, K. Bateman, R. Gordon, J. Mancini, and D. Riendeau Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1 J. Biol. Chem., June 4, 2004; 279(23): 24866 - 24872. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Koetzner, X.-Y. Hua, J. Lai, F. Porreca, and T. Yaksh Nonopioid Actions of Intrathecal Dynorphin Evoke Spinal Excitatory Amino Acid and Prostaglandin E2 Release Mediated by Cyclooxygenase-1 and -2 J. Neurosci., February 11, 2004; 24(6): 1451 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Chou, L.-P. Chang, C.-Y. Li, C.-S. Wong, and S.-P. Yang The Antiinflammatory and Analgesic Effects of Baicalin in Carrageenan-Evoked Thermal Hyperalgesia Anesth. Analg., December 1, 2003; 97(6): 1724 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Gajraj Cyclooxygenase-2 Inhibitors Anesth. Analg., June 1, 2003; 96(6): 1720 - 1738. [Full Text] [PDF] |
||||
![]() |
P. Ciceri, Y. Zhang, A. F. Shaffer, K. M. Leahy, M. B. Woerner, W. G. Smith, K. Seibert, and P. C. Isakson Pharmacology of Celecoxib in Rat Brain after Kainate Administration J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 846 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vasquez, K.-J. Bar, A. Ebersberger, B. Klein, H. Vanegas, and H.-G. Schaible Spinal Prostaglandins Are Involved in the Development But Not the Maintenance of Inflammation-Induced Spinal Hyperexcitability J. Neurosci., November 15, 2001; 21(22): 9001 - 9008. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yaksh, D. M. Dirig, C. M. Conway, C. Svensson, Z. D. Luo, and P. C. Isakson The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 J. Neurosci., August 15, 2001; 21(16): 5847 - 5853. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pacak and M. Palkovits Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders Endocr. Rev., August 1, 2001; 22(4): 502 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Gold Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia PNAS, July 6, 1999; 96(14): 7645 - 7649. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu and K. N. Westlund Gabapentin Attenuates Nociceptive Behaviors in an Acute Arthritis Model in Rats J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 214 - 219. [Abstract] [Full Text] |
||||